3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Vitamin D Deficiency
2
Triple Negative Breast Neoplasms
1
Obesity
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Colonic Neoplasms
1
Carcinoma, Intraductal, Noninfiltrating
1
Bone Metabolism Biomarkers
1
Interventions
Rituximab
43
Cyclophosphamide
37
Prednisone
25
Doxorubicin
24
Vincristine
19
Magnetic Resonance Spectroscopy
19
Lenalidomide
19
Gemcitabine
18
Specimen Handling
17
polatuzumab vedotin
14
Oxaliplatin
14
Biopsy
14
glofitamab
12
obinutuzumab
11
Etoposide
10
ibrutinib
9
fludarabine
8
Dexamethasone
8
CT-P10
8
pembrolizumab
7
Prednisolone
7
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
7
venetoclax
6
tafasitamab
6
prednylidene
6
deltacortene
6
acalabrutinib
6
fludarabine phosphate
5
R-CHOP protocol
5
Immunotherapy, Adoptive
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
Cholecalciferol
×
90 days
×
Clear all
No trials found.